Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.

Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS.

Aptar Digital Health today announced survey findings showcasing the impact of its iPump connected assistant for medication ...

Retractable Technologies (NYSE:RVP) announced today that it reduced its workforce by approximately 7%. The Little Elm, ...

San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...

Howard Look announced that he is stepping down from his role as CEO at automated insulin delivery technology developer ...

A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration.

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic care.